search
SPC
Trends
- 1SpaceX prepares Starship for first orbital launch attempt▼SpaceX prepares Starship rocket for first orbital launch (SPCX:NASDAQ)
SpaceX is readying its Starship rocket for its first attempt at reaching orbit. The test flight from the company's Starbase facility in Texas would mark a major milestone for the most powerful rocket ever built, a key part of NASA's plans to return astronauts to the Moon and of Elon Musk's long-term ambitions for Mars missions.
- 2SpaceX shares fall despite investment-grade rating on $20B bond deal▼SpaceX (SPCX) Fell Despite Investment-Grade Ratings — Why the $20B Bond Deal Matters
SpaceX launched a $20 billion bond deal that received investment-grade ratings, yet the company's shares fell nonetheless. The decline has drawn attention because strong credit ratings would normally support investor confidence. Analysts are weighing why markets reacted negatively to an otherwise milestone financing, and what the bond sale signals about SpaceX's capital needs and its expansion plans, including Starlink and launch operations.
- 3Space Stocks Stabilize After Rough July as Musk Backs NASA Moon Plans▼SPCX, ASTS, RKLB Find A Floor After Brutal July: Elon Musk Says NASA’s Moon Base Vision ‘Will Happen’
Space-related stocks including SpaceX-linked names, AST SpaceMobile and Rocket Lab found a floor after a difficult July of trading. Attention turned to Elon Musk's comment endorsing NASA's vision of a permanent Moon base, which he said 'will happen'. Investors are watching whether renewed Moon ambitions and Musk's remarks can restore confidence in the space sector after weeks of heavy selling.
- 4Musk's Nvidia Bet in Focus After SpaceX Earnings▼Elon Musk’s Big Nvidia Bet Takes Center Stage After SpaceX Earnings — NVDA Gains While SPCX Falls
SpaceX earnings are drawing attention to Elon Musk's reported large investment in Nvidia, with markets reacting in opposite directions: Nvidia shares rose while SpaceX-linked stock fell. The results put the chipmaker bet at the center of discussion about the space company's financial strategy and its reliance on expensive AI hardware.
- 5Government Weighs Scrapping National AI Project, Reports Say●Exclusive: Gov’t Weighs Ending National AI Project, Mulls SPC
Chosun Ilbo reports exclusively that the South Korean government is considering ending a national artificial intelligence project and is weighing a special purpose company structure as an alternative. The report has drawn attention to the fate of state-backed AI plans, with officials said to be reviewing whether the current approach should be abandoned or reorganised. Details of the project's scale and timeline were not disclosed.
- 6SpaceX IPO enlarged to $85.7 billion after greenshoe exercise▼SPCX Stock Extends Its Relentless Rally – SpaceX Expands Historic IPO To $85.7B After Underwriters Exercise Greenshoe Option
SpaceX's much-discussed IPO has been enlarged to $85.7 billion after underwriters exercised their greenshoe option, allowing additional shares to be sold at the offering price. Trading under the ticker SPCX, the stock has continued a strong rally since listing, extending gains as demand outstripped expectations. Commentators are calling it one of the largest public offerings in history, with attention on whether the momentum can hold once the post-IPO excitement fades.
- 7SpaceX Stock Surges 19% After IPO Debut▼SpaceX Stock Forecast: After a 19% IPO Surge, Can SPCX Keep Climbing Before Earnings?
Coverage claims SpaceX has gone public under the ticker SPCX and that shares jumped 19% in their debut, with analysts debating whether the stock can keep rising ahead of the company's first earnings report. Investors are weighing whether the post-IPO momentum is sustainable or driven by short-term hype. Note: SpaceX has not previously confirmed an IPO, so details remain uncertain.
- 8SpaceX shares fall 31% despite $100 billion cash pile●SpaceX (SPCX) Falls 31% From Its High — Why $100B in Cash Isn't Stopping the Selloff
SpaceX's stock has dropped 31% from its peak, with roughly $100 billion in cash failing to halt the selloff. Commentators point to a disconnect between the company's strong balance sheet and investor sentiment, as holders continue to offload shares amid doubts about valuation and near-term catalysts.
- 9SpaceX Lockup Expiry Passes Without Share Sell-Off▼SpaceX’s First Lockup Passed Without a Crash — Is the Supply Overhang Behind SPCX?
The first lockup period following SpaceX's public listing has ended, and SPCX shares did not crash as some had feared. Attention is now turning to whether lingering supply overhang — early holders still waiting to sell — will weigh on the stock, with analysts divided on how much selling pressure remains in the market.
- 10SpaceX Ticker Slides as Ex-Nasdaq Chief Questions Fundamentals●SpaceX Stock Forecast: SPCX Falls From $225 to $206 as Former Nasdaq Chief Warns It’s Not Trading on Fundamentals
A SpaceX-linked ticker, SPCX, dropped from $225 to $206, and a former Nasdaq chief warned the stock is not trading on fundamentals. The comment has stoked debate over whether the share price reflects the company's actual business prospects or speculative enthusiasm, with investors closely watching whether the decline continues.
- 11Oppenheimer raises SpaceX target citing Cursor deal upside▼SPCX Bull Case Strengthens — Oppenheimer Raises SpaceX Target, Sees More Upside After Cursor Deal
Oppenheimer has raised its price target for SPCX, the ticker tracking SpaceX, pointing to stronger upside following SpaceX's deal with Cursor. Analysts say the agreement strengthens the bull case for the company, and investors are weighing what the partnership means for SpaceX's valuation going forward.
- 12Study maps rational selection of adenine base editors for human genome editing●Rational selection of SpCas9 and variant-derived adenine base editors for human genome editing
A Nature publication describes a rational framework for choosing between SpCas9 and variant-derived adenine base editors when editing the human genome. The work aims to help researchers match editor choice to specific target sites and desired edits, improving precision in gene-editing applications. The paper is being circulated among readers following advances in CRISPR-based genome editing tools.